急性心肌梗死患者C反应蛋白浓度变化与梗死面积的相关性研究
出处
《临床荟萃》
CAS
2010年第10期879-881,共3页
Clinical Focus
参考文献9
-
1Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR) :Consensus Panel report[J]. Eur Heart J,2004,25(21) : 1940-1965.
-
2Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart[J]. Circulation,2002,105(4): 539-542.
-
3Armani A, Becher RC. The biology, utilization,and attenuation of C reactive protein in cardiovascular disease: Part Ⅰ[J]. Am Heart J,2005,149(6):971-976.
-
4严江涛,汪道文.C反应蛋白和心血管疾病[J].临床内科杂志,2009,26(1):5-7. 被引量:19
-
5Wagner A, Mahrholdt H, Holly TA, et ah Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection for detection of subendocardial myocardial infarcts; an imaging study [J]. Lancet,2003,361(9355) :374-379.
-
6Baks T,Cademartiri F, Moelker AD, et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction[J]. J Am Coll Cardiol, 2006,48(48) :144-152.
-
7Hsu LY, Natanzon A, Kellman P, et al. Quantitative myocardial infarction on delayed enhancement MRI. Part Ⅰ: animal validation of an automated feature analysis and combined thresh olding infarct sizing algorithn[J]. J Magn Reson Imaging,2006, 23(3) ,298-308.
-
8Saeed M, Lee R J, Weber O, et al. Scarred myocardium imposes additional burden on remote viable myoeardium despite a reduction in the extent of area with late contrast MR enhancement[J]. Eur Radiol,2006,16(4) :827-836.
-
9Yan AT,Shayne AJ,Brown KA,et al. Characterization of the peri infarct zone by contrast enhanced cardiac magnetic resonance imaging is a powerful predictor of post myocardial infarction mortality[J]. Circulation, 2006,114 (1):32-39.
二级参考文献25
-
1Armani A, Becher RC. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I. Am Heart J ,2005,149: 971-976.
-
2Devaraj S, Venugopal S, Jialal I. Native pentameric C-reactive protein displays more potent pro-atherogenie activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis, 2005,184: 48-52.
-
3Devaraj S,Du Clos TW ,Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol, 2005,26 : 1359-1363.
-
4Qamirani E, Ren Y, Kuo L, et al. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD (P) H oxidase. Arterioscler Thromb Vasc Biol, 2005,25:995-1001.
-
5Kibayashi E, Urakazal M,Kobashi C, et al. Inhibitory effect of pitavastatin (NK-104) on the C-reactive protein-induced interleukin-8 production in human aortic endothelial cell. Clin Sci (Lond) ,2005,108:515-521.
-
6Verma S, Badiwala MV, Weisel RD, et al. C-reactive protein upregulates the NF-κB signaling pathway in saphenous vein endothelial cells:implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg, 2003,126:1886-1891.
-
7Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation ,2002,106:913-919.
-
8Venugopal SK, Devaraj S, Jialal I, et al. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation, 2003,108 : 1676-1678.
-
9Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation ,2002,105 : 1890-1896.
-
10Wang CH,Li SH ,Weisel RD, et al. C-reactive protein upgratulates angiotensin type I receptors in vascular smooth muscle. Circulation ,2003, 107 : 1783-1790.
共引文献18
-
1王爱民,郧立杰,王立君.高敏C反应蛋白及脉压与冠状动脉病变程度的相关性研究[J].临床荟萃,2009,24(12):1075-1076.
-
2杨裕明.51例哮喘患儿白三烯和C反应蛋白检测分析[J].检验医学与临床,2009,6(18):1553-1554. 被引量:4
-
3陈年发,段永强.内皮素-1和C反应蛋白在单纯性肥胖儿童血管内皮细胞损伤中的作用[J].实用儿科临床杂志,2010,25(7):486-487. 被引量:7
-
4朱俊国,张林林,李勋.冠心病合并2型糖尿病患者冠状动脉病变特点及与高敏C-反应蛋白关系分析[J].河北医药,2010,32(10):1200-1202. 被引量:5
-
5汪香姣,段永强,陈年发,费世暖.肥胖儿童体质指数与血浆内皮素水平的关系及其干预措施[J].标记免疫分析与临床,2010,17(6):399-400.
-
6刘秋芳,唐爱华,周晓云,涂美玲.超敏C-反应蛋白整合Tch/HDL-C比值预测冠心病危险度水平[J].国际检验医学杂志,2010,31(12):1431-1432. 被引量:6
-
7潘桂红.肥胖儿童血浆内皮素检测的意义[J].国际检验医学杂志,2011,32(2):285-285. 被引量:2
-
8周晓莉.CRP、GSP与冠心病和糖尿病关系的研究现状[J].海南医学,2012,23(3):115-116. 被引量:3
-
9段永强,王佐兵,余辉.2型糖尿病患者C反应蛋白、脂联素和瘦素水平与胰岛素抵抗的相关性[J].标记免疫分析与临床,2012,19(2):86-88. 被引量:6
-
10侯瑞莲,李有香,董存元.C反应蛋白在支气管哮喘治疗中的应用进展[J].中国误诊学杂志,2012,12(9):2032-2033. 被引量:4
-
1韩丹娅,童传凤,王化敏.急性心肌梗死患者C反应蛋白浓度变化与梗死面积的相关性研究[J].临床内科杂志,2009,26(6):386-388. 被引量:1
-
2刘学耀.糖尿病患者防肾病[J].家庭医学(上半月),2001,16(10):56-56.
-
3赖红,陈耀忠.深圳市宝安区2010-2014年手足口病流行特征分析及防治探讨[J].中国初级卫生保健,2016,30(2):57-58.
-
4孙旭东,黄子扬,陈良龙,孙斌,陈智勇,段青.超声二维斑点追踪技术量化评价陈旧性心肌梗死患者左心室整体心肌梗死大小:与磁共振延迟强化成像对照研究[J].中国医学影像技术,2012,28(3):478-482. 被引量:6
-
5张青,王振常,赵波,鲜军舫,田其昌,张华,吴超,李岩,罗福燕,牛延涛,史旭波.心脏磁共振延迟强化成像定量评价心肌梗死的研究[J].临床荟萃,2007,22(10):696-699. 被引量:4
-
6孙旭东,黄子扬,陈良龙,孙斌,陈智勇,段青.二维斑点追踪成像与MRI识别陈旧性心肌梗死左室心尖各节段透壁程度对照研究[J].中国医学影像学杂志,2012,20(6):475-480. 被引量:6
-
715-内皮-脂氧素A4抑制髓过氧化物酶信号传导并促进急性肺损伤的缓解[J].中华医学信息导报,2009,24(13):13-13.
-
8张帆,杨新春.多层螺旋CT心血管成像技术的临床应用进展[J].心血管病学进展,2004,25(6):409-413. 被引量:1
-
9王蕾,冯笑山,毛毅敏,张剑青,孙瑜霞,张英民,吴丹,戴路明.COPD患者血清炎症介质水平在病情评估中的应用价值[J].中国地方病防治,2016,31(11):1279-1280. 被引量:1
-
10李羚,杨莉,唐珩,金蕊.黏附分子CD_(44)在哮喘气道炎症反应中的作用[J].中国当代儿科杂志,2009,11(2):142-145. 被引量:4